Combination therapies with PRRT

A Yordanova, H Ahmadzadehfar - Pharmaceuticals, 2021 - mdpi.com
Peptide receptor radionuclide therapy (PRRT) is a successful targeted radionuclide therapy
in neuroendocrine tumors (NETs). However, complete responses remain elusive. Combined …

[引用][C] Teranosztikumok 2020-ban: Neuroendokrin tumorok [Theranostics in 2020: Neuroendocrine tumors]

G Sipka, Z Besenyi, I Farkas, L Pávics - MAGYAR ONKOLÓGIA, 2020 - szte